DUBLIN, October 18, 2016 /PRNewswire/ — Research and Markets has announced the addition of the “TCR & CAR Engineered T-Cell and NK Cell Therapeutics 2016” report to their offering. The report, “TCR & CAR Engineered T-Cell and NK Cell Therapeutics 2016: Convergence of technologies opens business opportunities beyond CD19 CARTs” describes and analyzes the status of…